Department of Radiology
Found 46 results
Filters: Keyword is Brain Neoplasms  [Clear All Filters]
2024
Krugman J, Patel K, Cantor A, Snuderl M, Cooper B, Zan E, Radmanesh A, E Hidalgo T, Nicolaides T.  2024.  Pediatric glioblastoma in the setting of constitutional mismatch-repair deficiency treated with upfront lomustine and nivolumab.. Pediatr Blood Cancer. 71(1):e30757.
2023
Girvin F, Phan A, Steinberger S, Shostak E, Bessich J, Zhou F, Borczuk A, Brusca-Augello G, Goldberg M, Escalon J.  2023.  Malignant and Benign Tracheobronchial Neoplasms: Comprehensive Review with Radiologic, Bronchoscopic, and Pathologic Correlation.. Radiographics. 43(9):e230045.
2022
Das ABharadwaj, Tranos JAndrew, Zhang J, Wadghiri YZaim, Kim SGene.  2022.  Estimation of Contrast Agent Concentration in DCE-MRI Using 2 Flip Angles.. Invest Radiol. 57(5):343-351.
2021
Zhang J, Lemberskiy G, Moy L, Fieremans E, Novikov DS, Kim SGene.  2021.  Measurement of cellular-interstitial water exchange time in tumors based on diffusion-time-dependent diffusional kurtosis imaging.. NMR Biomed. 34(6):e4496.
2020
Chiang GC, Pisapia DJ, Liechty B, Magge R, Ramakrishna R, Knisely J, Schwartz TH, Fine HA, Kovanlikaya I.  2020.  The Prognostic Value of MRI Subventricular Zone Involvement and Tumor Genetics in Lower Grade Gliomas.. J Neuroimaging. 30(6):901-909.
2019
Ivanidze J, Roytman M, Lin E, Magge RS, Pisapia DJ, Liechty B, Karakatsanis N, Ramakrishna R, Knisely J, Schwartz TH et al..  2019.  Gallium-68 DOTATATE PET in the Evaluation of Intracranial Meningiomas.. J Neuroimaging. 29(5):650-656.
Seligman L, Kovanlikaya I, Pisapia DJ, Naeger DM, Magge R, Fine HA, Chiang GC.  2019.  Integrated PET-MRI for Glioma Surveillance: Perfusion-Metabolism Discordance Rate and Association With Molecular Profiling.. AJR Am J Roentgenol. 212(4):883-891.
Zhang S, Chiang GChia-Yi, Magge RS, Fine HAlan, Ramakrishna R, Chang EWang, Pulisetty T, Wang Y, Zhu W, Kovanlikaya I.  2019.  MRI based texture analysis to classify low grade gliomas into astrocytoma and 1p/19q codeleted oligodendroglioma.. Magn Reson Imaging. 57:254-258.
Ivanidze J, Lum M, Pisapia D, Magge R, Ramakrishna R, Kovanlikaya I, Fine HA, Chiang GC.  2019.  MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma.. J Neuroimaging. 29(3):357-363.
Lin F, Prince MR, Spincemaille P, Wang Y.  2019.  Patents on Quantitative Susceptibility Mapping (QSM) of Tissue Magnetism.. Recent Pat Biotechnol. 13(2):90-113.
Zhang J, Feng L, Otazo R, Kim SGene.  2019.  Rapid dynamic contrast-enhanced MRI for small animals at 7T using 3D ultra-short echo time and golden-angle radial sparse parallel MRI.. Magn Reson Med. 81(1):140-152.
Zhang S, Chiang GChia-Yi, Magge RS, Fine HAlan, Ramakrishna R, Chang EWang, Pulisetty T, Wang Y, Zhu W, Kovanlikaya I.  2019.  Texture analysis on conventional MRI images accurately predicts early malignant transformation of low-grade gliomas.. Eur Radiol. 29(6):2751-2759.
2018
Citak-Er F, Firat Z, Kovanlikaya I, Ture U, Ozturk-Isik E.  2018.  Machine-learning in grading of gliomas based on multi-parametric magnetic resonance imaging at 3T.. Comput Biol Med. 99:154-160.
Bae J, Zhang J, Wadghiri YZaim, Minhas ASingh, Poptani H, Ge Y, Kim SGene.  2018.  Measurement of blood-brain barrier permeability using dynamic contrast-enhanced magnetic resonance imaging with reduced scan time.. Magn Reson Med. 80(4):1686-1696.
2017
Galla N, Chiang G, Chakraborty S, Singh R, A Tsiouris J, Boockvar J, Kovanlikaya I.  2017.  Apparent diffusion coefficient changes predict survival after intra-arterial bevacizumab treatment in recurrent glioblastoma.. Neuroradiology. 59(5):499-505.
2016
Munjal S, Pahlajani S, Baxi A, Ferrando S.  2016.  Delayed Diagnosis of Glioblastoma Multiforme Presenting With Atypical Psychiatric Symptoms.. Prim Care Companion CNS Disord. 18(6)
Wang S, Martinez-Lage M, Sakai Y, Chawla S, Kim SG, Alonso-Basanta M, Lustig RA, Brem S, Mohan S, Wolf RL et al..  2016.  Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI.. AJNR Am J Neuroradiol. 37(1):28-36.
Reynaud O, Winters KVeronica, Hoang DMinh, Wadghiri YZaim, Novikov DS, Kim SGene.  2016.  Pulsed and oscillating gradient MRI for assessment of cell size and extracellular space (POMACE) in mouse gliomas.. NMR Biomed. 29(10):1350-63.
Reynaud O, Winters KVeronica, Hoang DMinh, Wadghiri YZaim, Novikov DS, Kim SGene.  2016.  Surface-to-volume ratio mapping of tumor microstructure using oscillating gradient diffusion weighted imaging.. Magn Reson Med. 76(1):237-47.
A Wernicke G, Lazow SP, Taube S, Yondorf MZ, Kovanlikaya I, Nori D, Christos P, Boockvar JA, Pannullo S, Stieg PE et al..  2016.  Surgical Technique and Clinically Relevant Resection Cavity Dynamics Following Implantation of Cesium-131 (Cs-131) Brachytherapy in Patients With Brain Metastases.. Oper Neurosurg (Hagerstown). 12(1):49-60.
Bander ED, Jones SH, Kovanlikaya I, Schwartz TH.  2016.  Utility of tubular retractors to minimize surgical brain injury in the removal of deep intraparenchymal lesions: a quantitative analysis of FLAIR hyperintensity and apparent diffusion coefficient maps.. J Neurosurg. 124(4):1053-60.
2015
Butler TA, Dugan P, French J.  2015.  Why is mesial temporal lobe epilepsy with Ammon's horn sclerosis becoming less common? Eur J Neurol. 22(1):e12.
2014
Wang S, Kim SJ, Poptani H, Woo JH, Mohan S, Jin R, Voluck MR, O'Rourke DM, Wolf RL, Melhem ER et al..  2014.  Diagnostic utility of diffusion tensor imaging in differentiating glioblastomas from brain metastases.. AJNR Am J Neuroradiol. 35(5):928-34.
Tan H, Liu T, Wu Y, Thacker J, Shenkar R, Mikati AGhani, Shi C, Dykstra C, Wang Y, Prasad PV et al..  2014.  Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping.. Invest Radiol. 49(7):498-504.
A Wernicke G, Yondorf MZ, Peng L, Trichter S, Nedialkova L, Sabbas A, Kulidzhanov F, Parashar B, Nori D, Chao KSClifford et al..  2014.  Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases.. J Neurosurg. 121(2):338-48.